Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests $101
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests $229
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  3. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  6. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  7. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  8. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  10. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  11. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  12. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  13. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  14. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  15. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  16. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  17. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  18. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  19. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  20. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  21. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  22. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  23. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  24. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  25. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  26. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  27. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  28. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  29. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  30. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  31. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  32. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  33. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  34. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  35. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  36. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  37. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  38. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  39. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  40. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  41. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  42. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  43. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  44. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  45. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  46. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  47. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  48. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  49. Jairaman A, et al. 2022. Elife. 11:. PubMed
  50. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  51. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  52. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  53. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  54. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  55. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  56. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  57. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  58. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  59. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  60. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  61. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  62. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  63. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  64. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  65. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  66. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  67. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  68. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  69. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  70. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  71. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  72. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  73. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  74. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  75. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  76. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  77. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  78. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  79. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  80. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  81. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  82. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  83. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  84. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  85. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  86. Ogbe A, et al. 2022. JCI Insight. . PubMed
  87. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  88. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  89. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  90. Woodruff MC, et al. 2022. Nature. :. PubMed
  91. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  92. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  93. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  94. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  95. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  96. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  97. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  98. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  99. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  100. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  101. Kumar V, et al. 2022. Cells. 11:. PubMed
  102. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  103. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  104. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  105. Vijayakumar B, et al. 2022. Immunity. . PubMed
  106. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  107. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  108. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  109. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  110. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  111. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  112. Dogra P, et al. 2020. Cell. 749:180. PubMed
  113. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  114. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  115. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  116. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  117. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  118. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  119. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  120. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  121. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  122. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  123. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  124. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  125. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  126. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  127. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  128. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  129. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  130. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  131. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  132. Kreutmair S, et al. 2021. Immunity. . PubMed
  133. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  134. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  135. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  136. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  137. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  138. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  139. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  140. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  141. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  142. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  143. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  144. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  145. Romine KA, et al. 2021. Cancer Discov. . PubMed
  146. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  147. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  148. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  149. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  150. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  151. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  152. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  153. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  154. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  155. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  156. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  157. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  158. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  159. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  160. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  161. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  162. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  163. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  164. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  165. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  166. Thijssen R, et al. 2022. Blood. :. PubMed
  167. Good Z, et al. 2022. Nat Med. :. PubMed
  168. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  169. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  170. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  171. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  172. Shi J, et al. 2014. Blood. 123:4015. PubMed
  173. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  174. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  175. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  176. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  177. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  178. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  179. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  180. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  181. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  182. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  183. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  184. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  185. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  186. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  187. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  188. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  189. Woodruff M, et al. 2020. medRxiv. . PubMed
  190. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  191. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  192. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  193. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  194. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  195. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  196. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  197. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  198. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  199. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  200. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  201. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  202. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  203. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  204. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  205. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  206. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  207. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  208. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  209. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  210. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  211. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  212. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  213. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  214. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  215. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  216. Burns JC, et al. 2020. eLife. 9:00. PubMed
  217. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  218. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  219. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  220. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  221. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  222. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  223. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  224. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  225. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  226. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  227. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  228. Wang J, et al. 2022. iScience. 25:103971. PubMed
  229. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  230. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  231. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  232. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  233. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  234. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  235. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  236. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  237. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  238. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  239. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  240. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  241. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  242. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  243. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  244. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  245. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  246. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  247. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  248. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  249. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  250. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  251. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  252. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  253. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  254. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  255. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  256. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  257. Feng W, et al. 2020. J Vis Exp. . PubMed
  258. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  259. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  260. Song M, et al. 2018. Nature. 562:423. PubMed
  261. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  262. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  263. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  264. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  265. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  266. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  267. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  269. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  270. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  271. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  272. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  273. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  274. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  275. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  276. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  277. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  278. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  279. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  280. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  281. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  282. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  283. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  284. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  285. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  286. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  287. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  288. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  289. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  290. Georg P, et al. 2022. Cell. 185:493. PubMed
  291. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  292. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  293. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  294. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  295. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  296. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  297. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  298. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  299. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  300. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  301. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  302. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  303. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  304. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  305. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  306. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  307. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  308. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  309. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  310. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  311. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  312. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  313. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  314. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  315. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  316. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  317. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  318. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  319. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  320. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  321. Lederer K, et al. 2022. Cell. . PubMed
  322. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  323. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  324. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  325. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  326. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  327. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  328. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  329. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  330. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  331. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  332. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  333. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  334. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  335. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  336. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  337. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  338. Adamo S, et al. 2022. Nature. 602:148. PubMed
  339. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  340. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  341. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  342. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  343. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  344. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  345. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  346. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  347. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  348. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  349. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  350. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  351. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  352. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  353. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  354. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  355. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  356. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  357. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  358. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  359. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  360. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  361. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  362. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  363. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  364. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  365. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  366. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  367. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  368. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  369. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  370. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  371. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  372. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  373. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  374. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  375. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  376. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  377. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  378. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  379. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  380. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  381. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  382. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  383. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  384. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  385. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  386. Chen C, et al. 2022. iScience. 25:103645. PubMed
  387. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  388. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  389. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  390. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  391. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  392. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  393. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  394. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  395. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  396. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  397. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  398. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  399. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  400. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  401. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  402. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  403. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  404. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  405. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  406. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  407. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  408. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  409. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  410. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  411. Wang EY, et al. 2021. Nature. 595:283. PubMed
  412. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  413. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  414. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  415. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  416. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  417. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  418. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  419. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  420. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  421. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  422. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  423. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  424. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account